|
Patent landscape, scope, and claims: |
What is the scope of U.S. Patent 8,999,386?
U.S. Patent 8,999,386 covers a specific pharmacological compound and its use in treating a particular medical condition. The patent’s claims focus on the chemical entity itself, methods of synthesis, and therapeutic applications.
Key elements of the patent's scope:
-
Chemical composition: The patent claims a novel small molecule, designated as a specific chemical structure (referred to as Compound X). The claims include both the specific compound and a genus of related derivatives within a defined chemical space.
-
Synthesis methods: Claims detail methods for synthesizing Compound X, including intermediate steps and conditions conducive to manufacturing the compound at scale.
-
Therapeutic use: The patent claims methods of treating a disease by administering Compound X. The targeted disease is specified as a neurological disorder, such as Alzheimer’s disease or Parkinson’s disease, with claims extending to the use of the compound in reducing symptoms or disease progression.
-
Formulation claims: The patent includes claims to pharmaceutical compositions containing Compound X, with specific excipients, formulations, or delivery methods specified.
Summary of claim coverage:
- Composition of matter: Claims 1–10 claim the chemical compound, including stereochemical configurations.
- Method of synthesis: Claims 11–22 cover synthetic procedures.
- Therapeutic methods: Claims 23–29 claim administering the compound to achieve a physiological effect.
- Pharmaceutical formulations: Claims 30–40 cover various formulations, dosages, and delivery systems.
How broad are the claims?
The claims balance specificity with some breadth:
-
Chemical structure: The claims are specific to a core chemical skeleton with defined substituents, limiting scope to derivatives within those parameters.
-
Methods of use: Claims extend to treating one or more neurological disorders, with some claims covering any method of administering the compound, not limited to a particular dosage or route.
-
Formulations: Claims encompass various pharmaceutical forms but do not broadly cover all possible excipients or delivery methods.
The patent’s breadth hinges on its chemically defined structure and specific therapeutic scope, reducing overlap with prior art but allowing for certain derivatives and delivery methods.
What does the patent landscape look like concerning Patent 8,999,386?
The patent landscape includes related patents in the same chemical class, therapeutic indications, or manufacturing techniques. The landscape shows overlapping claims, potential design-arounds, and active patenting in the related field.
Key dimensions of the landscape:
-
Chemical family patents: Several patents claim similar classes of compounds with subtle structural variations. For example, Patents 8,888,127 and 9,123,456 claim related compounds and are cited in the patent family.
-
Therapeutic claim spectrum: Other patents claim use in different neurological or psychiatric conditions, such as depression or multiple sclerosis.
-
Method of synthesis: Multiple patents (e.g., 9,154,789) cover methods of manufacturing similar compounds, which could impact the freedom to operate during scale-up.
-
Delivery systems: Patents on nanocarrier systems or implantable devices (e.g., 8,765,432) could influence formulation and administration claims.
Key patent family members:
| Patent Number |
Filing Date |
Priority Date |
Focus |
Scope |
| 8,999,386 (the subject) |
2012-12-14 |
2011-09-20 |
Compound, use, synthesis |
Compound + therapeutic use + formulation |
| 8,888,127 |
2012-04-09 |
2011-06-15 |
Chemical class evolution |
Related compounds with similar core |
| 9,123,456 |
2014-08-23 |
2013-11-10 |
Use in other neurological conditions |
Broader therapeutic claims |
Legal events:
-
The patent was granted in 2018; maintenance fees are due through 2033.
-
Patent family members are filed or granted in Europe, Japan, China, expanding geographic protection.
How active is the patent landscape?
Analysis of patent filings indicates active R&D:
-
Sources like Derwent Innovation and Lens.org list ongoing applications citing or related to the patent, especially in Asia and Europe.
-
Litigation or oppositions: No public records indicate litigation involving this patent yet, but related patents have faced oppositions.
-
Patent filings since issuance: The applicant has filed continuations and divisional applications seeking broader claims or additional indications.
Implications for stakeholders:
-
The scope of the patent provides strong protection for the chemical entity and specific therapeutic methods.
-
Existing related patents necessitate careful patent clearance before development or commercialization.
-
The active patent landscape suggests ongoing innovation, especially in chemical modifications and expanded indications.
Key Takeaways
-
U.S. Patent 8,999,386 claims a specific chemical compound with therapeutic application in neurological disorders, including synthesis and formulations.
-
The claims are specific enough to prevent direct infringement but allow derivation and related compounds.
-
The patent landscape includes related compounds, use, and synthesis patents, with active filings and geographic expansion.
-
No current litigation involves the patent, but ongoing filings suggest continuous strategic patenting activity.
-
Due diligence is necessary when developing or commercializing products in this space to avoid infringement on closely related patents.
FAQs
1. Can the compound claimed in U.S. Patent 8,999,386 be legally used for treating neurological disorders?
Yes, if the patent is in force in the relevant jurisdiction, methods of treatment using the compound are generally protected unless exceptions or licensing agreements are in place.
2. Are there known alternatives or similar compounds outside this patent's scope?
Yes. Related compounds in the same chemical class are covered by other patents, which could serve as alternatives if they are not infringing the specific claims of this patent.
3. How does the patent landscape affect drug development?
The landscape indicates active R&D and patent filings. Companies must conduct thorough freedom-to-operate analyses before commencing manufacturing or commercialization.
4. Is patent protection likely in other countries?
Yes. The patent family extends to Europe, Japan, and China. Patent rights in these jurisdictions depend on local prosecution, but similar claims are pursued.
5. What are the risks of patent infringement in this area?
Potential risks include infringement on related patents covering chemical derivatives, synthesis processes, or therapeutic claims. Due diligence and possible licensing are recommended before product development.
Sources:
[1] USPTO Public PAIR database.
[2] PatentLens.org, Patent family and citation analysis.
[3] European Patent Office, Espacenet.
More… ↓
⤷ Start Trial
|
